Creative Disruption Forum on Women's Leadership and Health Innovation inspired by International Women's Day

In celebration of Women's International Day (WID) on 8 March, we are dedicating this #CreativeDisruption Forum (CDF) on the 28 April to Women Leaders in #LifeSciences and #Tech plus sessions dedicated separately to the field of Women's Health Innovation. Here we will have key thought-leaders in STEM businesses share their success stories, discuss how far we have come, how to be a successful leader and what can be improved further.

Overview of Women Leaders in Biotech and Tech within Biopharma, Life Sciences, and Tech over the last Decade:

Over the last decade, the presence and influence of women leaders in biotech, biopharma, and tech have significantly increased, marked by their contributions to innovation, leadership roles, and advocacy for greater diversity in the industry. In 2013, women held only a fraction of executive positions in these fields, often facing barriers such as gender bias, lack of mentorship, and limited access to funding. However, the push for gender equality and diversity has gained momentum, supported by initiatives aimed at empowering women in STEM (science, technology, engineering, and mathematics). To list on NASDAQ currently, you have to have at least one woman on the board, for example.  We'll be hearing from women leaders in the field about their experiences and asking what more can be done to support women in business?

Overview of Women’s Health Innovation in Life Sciences

The last decade has witnessed a remarkable evolution in women’s health innovation, driven by a growing recognition of the unique health needs of women and the importance of gender-specific research. Historically, women's health issues were often underfunded and overlooked in clinical research and drug development. However, over the last decade, there has been a significant shift towards addressing these disparities.

Key innovations include advancements in reproductive health, menopause management, and maternal health technologies. The development of digital health platforms and telemedicine has empowered women to access health information and services more conveniently. Companies focusing on female-specific health issues, such as hormone replacement therapy, menstrual health, and fertility solutions, have emerged, gaining considerable traction in the market.

Moreover, advocacy for women's health has gained momentum, with organizations and movements striving to raise awareness about issues such as reproductive rights and gender bias in medical research. This decade has seen a collective effort to prioritize women's health, resulting in a more inclusive and innovative landscape in life sciences. The ongoing focus on women's health is likely to lead to further advancements and improved health outcomes in the years to come.  We'll be hearing from leaders of women's health innovation businesses about the scope of the opportunities, and what new technologies are already being developed.

Chatham House Rules apply - "what goes on in the Forum, stays in the Forum - so to speak!"

Who should attend

The #CreativeDisruption Forum is designed for professionals working in life sciences who are driving innovation and growth. It is ideal for:

• Founders and executives of biotech, medtech, and healthtech companies
• R&D and clinical development leaders
• Investors and business strategists in the healthcare sector
• Innovation managers, consultants, and academic partners involved in commercialisation
• Students and early-career researchers interested in understanding how scientific innovation translates into successful business ventures